Kamat - Figure 14
Recurrence-free Survival
FIG. 14: In the study mentioned in the previous Figure,[12] maintenance therapy had a clear benefit for decreasing recurrences and increasing length of recurrence-free survival in patients with NMI bladder cancer. This is important, because there is a discussion worldwide about whether BCG has the same effects in different patient populations using different protocols of BCG immunotherapy.
References
[12]
Hinotsu S, Akaza H, Naito S, et al. Maintenance therapy with bacillus Calmette-Guérin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer. BJU Int. 2011;108:187−195 https://doi.org/10.1111/j.1464-410X.2010.09891.x